Network origin in Susan Vermeir first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Subsidiary | Biotechnology | 36 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Susan Vermeir via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Elan Pharmaceuticals, LLC
 Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Sales & Marketing General Counsel Corporate Officer/Principal Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
CoTherix, Inc.
 CoTherix, Inc. Pharmaceuticals: MajorHealth Technology CoTherix, Inc. develops therapeutic products. Its ventavis product is a nebulizer delivered therapy for pulmonary artery hypertension, which restricts blood flow to the lungs. CoTherix markets its products in the US, Europe, and Australia. The company was founded in February, 2000 by Donald J. Santel and Gerard Turino and is located in Brisbane, CA. | Pharmaceuticals: Major | Chairman Founder Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| University of California, Berkeley | College/University | Graduate Degree Undergraduate Degree Masters Business Admin Undergraduate Degree | |
Sofinnova Investments, Inc.
 Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor Private Equity Investor | |
| ZOGENIX, INC. | Pharmaceuticals: Major | Founder Corporate Officer/Principal Corporate Officer/Principal Sales & Marketing | |
| ULTRAGENYX PHARMACEUTICAL INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chairman Director/Board Member | |
Alveo Technologies, Inc.
 Alveo Technologies, Inc. Medical SpecialtiesHealth Technology Alveo Technologies, Inc. operates a pre-clinical stage medical diagnostics company that creates infectious disease diagnostic devices. The company was founded by Ron Chiarello, Michael A. Aicher, Lawrence M. Blatt and Sumita Pennathur in 2014 and is headquartered in Alameda, CA. | Medical Specialties | Director/Board Member Director/Board Member | |
| ALIGOS THERAPEUTICS, INC. | Pharmaceuticals: Major | President Founder | |
| DARÉ BIOSCIENCE, INC. | Pharmaceuticals: Major | Founder Director/Board Member | |
| University of California, Davis | College/University | Doctorate Degree Undergraduate Degree | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| University of California, Los Angeles | College/University | Undergraduate Degree Graduate Degree | |
| CORIUM INTERNATIONAL INC | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
| Stanford University | College/University | Undergraduate Degree Undergraduate Degree | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| CYTOKINETICS, INCORPORATED | Pharmaceuticals: Major | Director of Finance/CFO Director of Finance/CFO | |
Bausch Health Americas, Inc.
 Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Bausch Health Americas, Inc. manufactures and distributes pharmaceutical products. The company was founded on November 29, 2011 and is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing | |
| PROTHENA CORPORATION PLC | Biotechnology | Chairman Director/Board Member | |
| STRUCTURE THERAPEUTICS INC. | Miscellaneous Commercial Services | Chairman Comptroller/Controller/Auditor | |
| The University of North Carolina at Charlotte | College/University | Masters Business Admin Graduate Degree | |
| Purdue University | College/University | Undergraduate Degree Undergraduate Degree | |
Prestwick Pharmaceuticals, Inc.
 Prestwick Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Prestwick Pharmaceuticals, Inc. develops drugs for diseases related to the central nervous system. Its drugs are used in curing diseases such as Huntington's, Parkinson's, restless legs syndrome, schizophrenia, autism, Alzheimer's, and sleep apnea diseases. The company was founded in 2002 and is headquartered in Washington DC. | Pharmaceuticals: Major | President Corporate Officer/Principal | |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing | |
| EIGER BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Founder Investor Relations Contact | |
| HYPERION THERAPEUTICS INC | Pharmaceuticals: Major | Chairman Director/Board Member | |
Amphivena Therapeutics, Inc.
 Amphivena Therapeutics, Inc. Drugstore ChainsRetail Trade Amphivena Therapeutics, Inc. provides drug discovery services. It develops tetravalent, T-cell redirecting bispecific antibodies for the treatment of hematologic malignancies. The firm’s’ lead drug candidate is AMV-564, a CD33/CD3-targeting treatment for acute myeloid leukemia (AML), which Amphivena is currently preparing to advance into clinical development. The company was founded by Jeanmarie Guenot in December 2012 and is headquartered in San Francisco, CA. | Drugstore Chains | Chief Executive Officer Chairman | |
| Brigham Young University | College/University | Undergraduate Degree Undergraduate Degree | |
| GSK PLC | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
Prometheus Laboratories, Inc.
 Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Prometheus Laboratories, Inc. develops and commercializes novel pharmaceutical and diagnostic products. Its enables physicians to provide individualized patient care. It applies the principles of personalized medicine to the diagnosis and treatment of gastrointestinal diseases and applies it to oncology. The firms markets and promotes pharmaceutical products and complementary proprietary diagnostic testing services. The company was founded by Jonathan Braun, Stephan R. Targan, Michael J. Walsh, and Scott L. Glenn in 1995 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing | |
| United States Congress Joint Economic Committee | Corporate Officer/Principal | ||
| INTERCEPT PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| GILEAD SCIENCES, INC. | Biotechnology | Director of Finance/CFO | |
| NUVATION BIO INC. | Biotechnology | Chairman | |
Nuvation Bio Operating Co., Inc.
 Nuvation Bio Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Nuvation Bio Operating Co., Inc. engages in the provision of biotechnology company developing proprietary therapies focuse on oncology. It portfolio includes Seven Novel and Mechanistically Distinct Oncology Programs, Each with Multiple Drug Development Candidates. The company was founded by David Hung in 2018 and is headquartered in New York, NY. | Pharmaceuticals: Major | Chairman | |
InCarda Therapeutics, Inc.
 InCarda Therapeutics, Inc. BiotechnologyHealth Technology InCarda Therapeutics, Inc. develops cardiovascular disease treatment through pulmonary delivery of established drugs. It also develops an inhaled therapy intended to treat paroxysmal atrial fibrillation. The company was founded by Narasimhan Rangachari, John S. Patton, Gregory M. Marcus and Carlos A. Schuler in 2009 and is headquartered in Newark, CA. | Biotechnology | Chairman | |
Levo Therapeutics, Inc.
 Levo Therapeutics, Inc. BiotechnologyHealth Technology Levo Therapeutics, Inc. operates as a pharmaceutical company. The company is headquartered in Glenview, IL. | Biotechnology | Chairman | |
| Adria Laboratories | Corporate Officer/Principal |
Statistics
International
| United States | 48 |
| Ireland | 3 |
| United Kingdom | 2 |
Sectoral
| Health Technology | 39 |
| Consumer Services | 8 |
| Finance | 2 |
| Commercial Services | 2 |
| Retail Trade | 2 |
Operational
| Director/Board Member | 157 |
| Corporate Officer/Principal | 87 |
| Chairman | 50 |
| Independent Dir/Board Member | 45 |
| Undergraduate Degree | 33 |
Most connected contacts
| Insiders | |
|---|---|
| Michael Smith | 56 |
| William Ringo | 32 |
| David Kabakoff | 30 |
| Daniel Welch | 24 |
| Lars Ekman | 21 |
| William Halter | 19 |
| Peter van Vlasselaer | 15 |
| Robin Steele | 13 |
| Roger L. Hawley | 13 |
| Sharon Barbari | 12 |
| James Pennington | 12 |
| Karen S. Wright | 12 |
| Thomas Kassberg | 12 |
| David Cory | 12 |
| Curtis L. Ruegg | 11 |
- Stock Market
- Insiders
- Susan Vermeir
- Company connections
